Genetic testing is used to identify patients with chronic lymphocytic leukemia (CLL) who are poor candidates for conventional chemoimmunotherapy. H......READ MORE
by Jennifer R. Brown, MD, PhD; Anthony Mato, MD, MSCE; and Susan O’Brien, MD
Younger, fit patients with chronic lymphocytic leukemia (CLL) are often interested in time-limited therapies such as fludarabine, cyclophosphamide,......READ MORE
by Jennifer R. Brown, MD, PhD; Anthony Mato, MD, MSCE; and Susan O’Brien, MD
The over-70 age group is highly represented among those starting treatment for chronic lymphocytic leukemia (CLL). Frontline treatment in this popu......READ MORE
clinical topic updates by Jennifer R. Brown, MD, PhD; Anthony Mato, MD, MSCE; and Susan O’Brien, MD
Richter transformation (RT) represents a spectrum of disease that can involve progression to a number of hematologic diseases. Recent evidence sugg......READ MORE
Tumor lysis syndrome (TLS) is a rare complication of contemporary chronic lymphocytic leukemia (CLL) treatment with potential clinical consequences......READ MORE
Patients with chronic lymphocytic leukemia (CLL) who are treated initially by watch and wait benefit from receiving appropriate vaccinations and ca......READ MORE
